Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yong Lai Park
Expression of Epithelial–mesenchymal Transition Driver Brachyury and Status of Tumor-Infiltrating CD8+ and FOXP3+ Lymphocytes in Predicting Treatment Responses to Neoadjuvant Chemotherapy of Breast Cancer
Tumor Biology
Medicine
Cancer Research
Predictors for the Transition From Ductal Carcinoma ≪i>In Situ</I> To Invasive Breast Cancer in Korean Patients
Journal of Breast Disease
Related publications
Prognostic Significance of Expression of Epithelial‑mesenchymal Transition Driver Brachyury in Breast Cancer and Its Association With Subtype and Characteristics
Oncology Letters
Cancer Research
Oncology
Erratum To: Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Breast Cancer and Its Clinical Significance
Breast Cancer Research
Cancer Research
Oncology
P058 Effects of Neoadjuvant Chemotherapy on the Expression of PD-L1 and Tumor Infiltrating Lymphocytes in Lung Cancer Tissues
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
JCSE01.14 Effects of Neoadjuvant Chemotherapy on the Expression of Programmed Death Ligand-1 and Tumor Infiltrating Lymphocytes in Lung Cancer Tissues
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.04-07 Effects of Neoadjuvant Chemotherapy on the Expression of Programmed Death Ligand-1 and Tumor Infiltrating Lymphocytes in Lung Cancer Tissues
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Distribution of CD4+ and CD8+ Exhausted Tumor-Infiltrating Lymphocytes in Molecular Subtypes of Chinese Breast Cancer Patients
OncoTargets and Therapy
Oncology
Pharmacology
Clinical Significance of Tumor-Infiltrating Lymphocytes in Breast Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers Treated With Neoadjuvant Chemotherapy
Targeted Oncology
Cancer Research
Oncology
Pharmacology
Value of TP53 Status for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis
PLoS ONE
Multidisciplinary
